The COVID-19 pandemic caused by SARS-CoV-2 coronavirus threatens global public health. Currently, neutralizing antibodies (NAbs) versus this virus are expected to correlate with recovery and protection of this disease. However, the characteristics of these antibodies have not been well studied in association with the clinical manifestations in patients
[2]
.Original Source [3]
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/feature-article/neutralizing-antibody-responses-sars-cov-2-covid-19-recovered-2-patient-cohort-and
[2] http://www.indiaenvironmentportal.org.in/files/file/Neutralizing-antibody.pdf
[3] https://www.medrxiv.org/content/10.1101/2020.03.30.20047365v1.full.pdf
[4] http://admin.indiaenvironmentportal.org.in/category/author/fan-wu
[5] http://admin.indiaenvironmentportal.org.in/category/author/aojie-wang
[6] http://admin.indiaenvironmentportal.org.in/category/author/mei-liu-et-al
[7] http://admin.indiaenvironmentportal.org.in/category/journal/medrxiv
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/coronavirus
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/medical-research
[10] http://admin.indiaenvironmentportal.org.in/category/thesaurus/infectious-diseases
[11] http://admin.indiaenvironmentportal.org.in/category/thesaurus/viral-diseases
[12] http://admin.indiaenvironmentportal.org.in/category/thesaurus/diagnostic-methods
[13] http://admin.indiaenvironmentportal.org.in/category/thesaurus/china
